Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Pharmaceutical Science

Two major studies strengthen case for prostate cancer drug before chemotherapy

Pioneering prostate cancer drug abiraterone significantly extends the lives of men with advanced prostate cancer if given before chemotherapy, the results of a major phase III clinical trial have shown.

The results, published in Lancet Oncology, showed that men with advanced, aggressive prostate cancer lived more than four months longer on average if they… Two major studies strengthen case for prostate cancer drug before chemotherapy   



diagnostic tests1 - long-term dialysis1 - journal of the national cancer institute1 - glans1 - adrenal hyperplasia1 - renal capsule1 - spop gene1 - bss1 - bladder control loss1 - kidney research1 - urinary tract infections8 - sexually transmitted infections1 - internal and external genitalia1 - acute renal failure1 - urinary calcium1 - malaria1 - physical activity5 - reduced potassium secretion1 - genitourinary tract2 - mucosal irritation1 - pyuria1 - renal pain1 - triamterene stones1 - kidney injury6 - stone recurrence1 - renal tubules1 - noninvasive imaging1 - myelomatosis1 - fred hutchinson cancer research center1 - xtandi1 -